Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eppendorf SE
Original Assignee
Eppendorf SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10053783Aexternal-prioritypatent/DE10053783B4/en
Priority claimed from DE10109618Aexternal-prioritypatent/DE10109618A1/en
Application filed by Eppendorf SEfiledCriticalEppendorf SE
Priority claimed from PCT/EP2001/007789external-prioritypatent/WO2002004603A2/en
Application grantedgrantedCritical
Publication of DE50114600D1publicationCriticalpatent/DE50114600D1/en
Modifying antigen-presenting cells, useful e.g. in antitumor vaccines, by transfer to them of antigen-containing membrane fragments from diseased cells